Skip to main content

Table 1 Demographic and clinical variables of all participants

From: Functional connectivity of the visual cortex differentiates anxiety comorbidity from episodic migraineurs without aura

  MwoA-A MwoA-OA HCs F/χ2 p value
Age (years) 34.41 ± 9.75 34.91 ± 12.14 33.40 ± 7.43 0.123 0.885
Sex (male/female) 1/26 6/16 3/17 5.347 0.068
Education (years) 13.44 ± 3.24 11.23 ± 2.56 14.00 ± 3.29 5.019 0.009
Disease duration (years) 7.11 ± 5.51 7.50 ± 6.77 / 2.930 0.824
Frequency (days/month) 4.22 ± 2.19 4.45 ± 3.00 / 0.754 0.390
Attack duration (hours) 13.22 ± 9.00 16.14 ± 12.79 / 3.590 0.355
HIT-6 score 61.26 ± 10.21 57.05 ± 7.64 / 1.733 0.116
VAS score 6.48 ± 1.42 6.45 ± 1.30 / 0.283 0.946
GAD-7 score 9.15 ± 3.30 2.59 ± 1.44 / 16.309 < 0.001
 Gy matter (mm3) 621.77 ± 56.10 632.93 ± 55.92 634.71 ± 56.26 0.382 0.684
White matter (mm3) 484.84 ± 46.65 489.76 ± 44.96 487.40 ± 49.17 0.067 0.935
Cerebrospinal fluid (mm3) 208.77 ± 21.90 216.85 ± 17.50 218.56 ± 31.41 1.167 0.318
Brain parenchyma (mm3) 1106.61 ± 90.37 1122.69 ± 93.20 1122.11 ± 90.32 0.247 0.782
  1. Data are presented as mean ± standard deviation. Abbreviations: GAD-7 Generalized Anxiety Disorder seven-item scale; HCs healthy controls; HIT-6 Headache Impact Test-6; MwoA-A migraine without aura with anxiety; MwoA-OA migraine without aura without anxiety; VAS Visual Analogue Scale